Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial

التفاصيل البيبلوغرافية
العنوان:	Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial
المؤلفون:	Ascierto, PA, Casula, M, Bulgarelli, J, Pisano, M, Piccinini, C, Piccin, L, Cossu, A, Mandalà, M, Ferrucci, PF, Guidoboni, M, Rutkowski, P, Ferraresi, V, Arance, A, Guida, M, Maiello, E, Gogas, H, Richtig, E, Fierro, MT, Lebbe, C, Helgadottir, H, Queirolo, P, Spagnolo, F, Tucci, M, Del Vecchio, M, Cao, MG, Minisini, AM, De Placido, S, Sanmamed, MF, Mallardo, D, Paone, M, Vitale, MG, Melero, I, Grimaldi, AM, Giannarelli, D, Dummer, R, Sileni, VC, Palmieri, G
المصدر:	Nature communications. 15(1):146
مصطلحات موضوعية:	Medicin och hälsovetenskap
الوصول الحر:	http://kipublications.ki.se/Default.aspx?queryparsed=id:238167503Test
قاعدة البيانات:	SwePub

الوصف
تدمد:	20411723
DOI:	10.1038/s41467-023-44475-6